ä¿ëÁ¤º¸ °Ë»ö
¼º¼öµ¿¹è¾çÀü¹®¿¬±¸¼ÒÀÇ genome Á¦³×¸¯ ¿¬±¸¿øÃ¤¿ë(¼®»ç1¸í¹Ú»ç1¸í)
![]() |
2020-02-03 |
||
|---|---|---|---|
| °í°´»ç | ÈÞ¸Ê |
| ÀÇ·ÚÀÏ | 2020-01-14 |
| ¸¶°¨ÀÏ | ä¿ë½Ã±îÁö. |
| ÇÁ·ÎÁ§Æ®¸í | ¼º¼öµ¿¹è¾çÀü¹®¿¬±¸¼ÒÀÇ genome ¿¬±¸¿øÃ¤¿ë(¼®»ç1¸í¹Ú»ç1¸í) |
| ÁøÇà»óÅ | ÁøÇàÁß |
| ȨÇǰø°³ | ȨÆäÀÌÁö °ø°³ |
| ¿¬ºÀ | |
| Á÷Ã¥/Á÷±Þ | ¼ö¼®,Ã¥ÀÓ¿¬±¸¿ø |
| ³ªÀÌ | ¹«°ü |
| Çз | ¼®»çÀÌ»ó |
| ¿Ü±¹¾î | |
| ±Ù¹«Áö | ¼¿ï½Ã¼º¼öµ¿¼º¼ö¿ªskŸ¿ö |
| ¼ºº° | ¹«°ü |
| ´ã´ç¾÷¹« ¹× ÀÚ°Ý¿ä°Ç | [´ã´ç¾÷¹«] -dna cloning -targeting vector construction´É¼÷ÀÚ [ÀÚ°Ý¿ä°Ç] CRISPR °ü·Ã ½ÇÇè À¯°æÇèÀÚ Cre-loxP [±Ù¹«Áö/ó¿ìÁ¶°Ç] ¼ºµ¿±¸¼º¼öµ¿ ¼®»ç±Þ 6000¸¸¿ø ¹Ú»ç±Þ 7000¸¸¿ø [ÀüÇüÀýÂ÷] ¼·ùÀüÇü-ÀÓ¿ø¸éÁ¢-ÇÕ°Ý¿ÀÆÛ·¹ÅÍ [Á¦Ãâ¼·ù] ÃÊ·Ï³í¹® °æ·Â±â¼ú¼ ÇØ¸®Æ¼Áö¼Ä¡ÄÚ¾îÀ̷¼ [Âü°í»çÇ×] 2018³â 5¿ù 16ÀÏ ¹ýÀμ³¸³ 2018³â 5¿ù Seed investment (Bluepoint partners) 2018³â 7¿ù Seed(2nd) investment (Bluepoint partners) |
| ¡¤ Á¢¼ö¹æ¹ý | |
| ¸¶°¨ÀÏ | ¸¶°¨ |
|---|---|
| ÀüÇüÀýÂ÷ | ¼·ùÀüÇü/¸éÁ¢ |
| Á¦Ãâ¼·ù | ±¹¹®À̷¼(±¸Ã¼ÀûÀÎ °æ·Â±â¼ú Æ÷ÇÔ) |
| ¡¤ ´ã´çÄÁ¼³ÅÏÆ® | |
| ´ã´çÄÁ¼³ÅÏÆ® |
¹Ú±â¼® ÀÌ»ç anon13@leenpartner.com |
|---|---|









